Tune in to my conversation with Mette Dyhrberg, Founder and CEO of Mymee. Mymee is a digital care platform designed to help individuals manage autoimmune diseases like arthritis, ankylosing spondylitis, lupus, and long COVID. They combine a mobile app, data analytics, and certified health coaches for their clinically-validated solution. They've raised a little over $15M from New York ventures, Half Court Ventures, and others.

And today, we chat about Mette's founder journey, the challenges of and opportunities in dealing with autoimmune disease, how she views being insurer- and practitioner-friendly, her unique business model in healthtech, the debate between RCTs and personalized medicine, raising venture funding, and so much more.

Timestamps:

00:00 Introduction!

00:45 Understanding Mymee's Mission

02:47 Challenges in Autoimmune Healthcare

04:23 The Mymee Method Explained

05:51 Patient Experience and Journey

10:22 The Role of Triggers in Autoimmune Diseases

18:02 Innovative Business Model and Market Strategy

22:22 Passion and Challenges in Healthtech

25:06 The Rise of Behavioral Change Companies

25:27 The Impact of COVID on Digital Health

26:37 Personalized Medicine vs. Western Medicine

28:46 Challenges in Medical Trials and Innovations

33:21 Creative Solutions in Business and Medicine

35:44 Startup Strategies and Team Building

37:29 Patient Advocacy and Autoimmune Conditions

45:29 The Future of Quantified Self and Wellness

This is Episode 004 of The Sherveen Show.

Follow Sherveen on X: https://www.x.com/sherveen

Follow Mette: https://x.com/metamette

Hosted on Acast. See acast.com/privacy for more information.